These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26560704)

  • 1. Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy.
    Mott DJ; Najafzadeh M
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):33-9. PubMed ID: 26560704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
    Brett Hauber A; Fairchild AO; Reed Johnson F
    Appl Health Econ Health Policy; 2013 Aug; 11(4):319-29. PubMed ID: 23637054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.
    Wortley S; Tong A; Lancsar E; Salkeld G; Howard K
    BMC Med Inform Decis Mak; 2015 Jul; 15():52. PubMed ID: 26166149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying Preferences in Drug Benefit-Risk Decisions.
    Tervonen T; Angelis A; Hockley K; Pignatti F; Phillips LD
    Clin Pharmacol Ther; 2019 Nov; 106(5):955-959. PubMed ID: 30929257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management.
    Jackson Y; Janssen E; Fischer R; Beaverson K; Loftus J; Betteridge K; Rhoten S; Flood E; Lundie M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):383-396. PubMed ID: 31070048
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences.
    Danner M; Hummel JM; Volz F; van Manen JG; Wiegard B; Dintsios CM; Bastian H; Gerber A; Ijzerman MJ
    Int J Technol Assess Health Care; 2011 Oct; 27(4):369-75. PubMed ID: 22004779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-centric HTA: different strokes for different folks.
    Mühlbacher AC
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):591-7. PubMed ID: 25896756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice Experiments to Quantify Preferences for Health and Healthcare: State of the Practice.
    Mühlbacher A; Johnson FR
    Appl Health Econ Health Policy; 2016 Jun; 14(3):253-66. PubMed ID: 26992386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective.
    Mühlbacher AC; Juhnke C; Beyer AR; Garner S
    Value Health; 2016; 19(6):734-740. PubMed ID: 27712699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' preferences in anticoagulant therapy: discrete choice experiment.
    Najafzadeh M; Gagne JJ; Choudhry NK; Polinski JM; Avorn J; Schneeweiss SS
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):912-9. PubMed ID: 25387782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.
    Marsh K; van Til JA; Molsen-David E; Juhnke C; Hawken N; Oehrlein EM; Choi YC; Duenas A; Greiner W; Haas K; Hiligsmann M; Hockley KS; Ivlev I; Liu F; Ostermann J; Poder T; Poon JL; Muehlbacher A
    Value Health; 2020 Jul; 23(7):831-841. PubMed ID: 32762984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives.
    van Overbeeke E; Forrester V; Simoens S; Huys I
    Patient; 2021 Jan; 14(1):119-128. PubMed ID: 32856278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is Next for Patient Preferences in Health Technology Assessment? A Systematic Review of the Challenges.
    Huls SPI; Whichello CL; van Exel J; Uyl-de Groot CA; de Bekker-Grob EW
    Value Health; 2019 Nov; 22(11):1318-1328. PubMed ID: 31708070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence, values, and decision making.
    Rawlins MD
    Int J Technol Assess Health Care; 2014 Apr; 30(2):233-8. PubMed ID: 24774475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.
    Beresniak A; Medina-Lara A; Auray JP; De Wever A; Praet JC; Tarricone R; Torbica A; Dupont D; Lamure M; Duru G
    Pharmacoeconomics; 2015 Jan; 33(1):61-9. PubMed ID: 25230587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.